Clinical Trial Update: Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Dexrazoxane hydrochloride to prevent heart-related side effects of chemotherapy in people with blood cancers; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukaemia
• Chronic Myeloid Leukemia Blast Phase
• Myelodysplastic Syndrome
• Myeloid Sarcoma
• Myeloproliferative Neoplasm

Drugs mentioned

• Dexrazoxane hydrochloride (Dexrazoxane)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 2 | Status: RECRUITING